Workflow
Dynamo Series smart stretcher
icon
Search documents
Baxter(BAX) - 2025 Q4 - Earnings Call Presentation
2026-02-12 13:30
Fourth -Quarter 2025 Earnings Baxter International Inc. February 12, 2026 1 Forward-Looking Statements To supplement Baxter's consolidated financial statements presented on a U.S. GAAP basis, the company discloses certain non-GAAP financial measures. These non-GAAP financial measures are not in accordance with generally accepted accounting principles in the United States. A reconciliation of the non-GAAP financial measures included in this document to the corresponding U.S. GAAP measures follows in the sect ...
Baxter Unveils Dynamo Smart Stretcher to Improve Hospital Safety
ZACKS· 2026-01-14 16:46
Company Overview - Baxter International Inc. (BAX) is set to launch its Dynamo Series smart stretcher in the U.S., enhancing its portfolio of connected care solutions for hospital environments [1][8] - The stretcher aims to support care teams in high-pressure settings while improving patient safety, comfort, and workflow efficiency [1][4] Product Features - The Dynamo Series stretcher features an electric design that reduces patient transfers, incorporates fall-prevention technology, and offers flexible positioning options for various procedures [8][9] - It includes advanced safety features such as the SafeView+ system for visual safety cues and a three-mode bed exit alarm for real-time alerts [10] - The stretcher provides one of the widest care surfaces in its category, enhancing stability and comfort for patients of different sizes [11] Strategic Focus - The launch reflects Baxter's commitment to practical innovation in acute care, particularly in emergency and perioperative settings [2] - The Dynamo Series is part of Baxter's strategy to strengthen its Care & Connectivity segment with technology-enabled products that address clinical challenges [2][4] Market Context - Baxter's market capitalization currently stands at $10.36 billion [6] - The global smart hospital beds market is projected to grow from $523.7 million in 2024 to $1 billion by 2034, with a CAGR of 7.3%, driven by demand for patient-centered care and hospital automation [12] Stock Performance - Following the announcement of the Dynamo Series, BAX shares traded flat in the after-market session, having lost 31.1% over the past six months compared to a 7.2% decline in the industry [3]